Massachusetts Lotronex Lawyers

If you have been injured as a result of the pharmaceutical drug Lotronex, click here to get a free case evaluation.

Lotronex (alosetron hydrochloride, a Glaxo Wellcome product) was initially approved by the FDA on February 9, 2000 for the treatment of Irritable Bowel Syndrome (IBS). IBS is a common and debilitating digestive disorder that afflicts an estimated 15% of the U.S. population, mostly women. IBS causes lower abdominal pain and discomfort and irregular bowel habits such as diarrhea or constipation.

Between approval and June 1, 2000 the FDA received seven reports of serious complications of constipation and reports of ischemic colitis. These resulted in hospitalizations, and surgical procedures.

On November 28, 2000 Glaxo announced that it would voluntarily withdraw Lotronex from the market.

If you have been injured as a result of the pharmaceutical drug such as Lotronex, click here to get a free case evaluation.